Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV
NCT ID: NCT01157442
Last Updated: 2011-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
856 participants
INTERVENTIONAL
2010-07-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specific objectives are:
1\. To determine if mobile phone SMS text messages can demonstrate an improvement in compliance with a known intervention ( use of nevirapine) for PMTCT, demonstrated by:
1a) improved antenatal care attendance (greater than 4 visits)
1b) increased usage of nevirapine in labour (from 60% to at least 70%)
1c) earlier identification and treatment of HIV positive infants
1d) increased postpartum care for HIV positive mothers
1e) acceptability of cell phone SMS text messages transmission of information among HIV positive women
2\. To demonstrate that mobile phone technology can be used as an effective tool to strengthen PMTCT health information systems at the facility level by: 2a) determining factors that constrain or promote the use of cell phone technology to strengthen PMTCT health information systems from the perspective of patients, health care providers and policy makers 2b) determining how cell phones can be used as a tool to generate equity statistics for PMTCT programs and formulate equity orientated PMTCT policies 2c) determine if early involvement of policy makers in the study improves knowledge translation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ART
NCT02400671
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
NCT06088277
Text Messaging to Improve HIV Testing Among Young Women in Kenya
NCT02527135
Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya
NCT00830622
Motivation Matters Study
NCT02627365
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cell phone sms messages
The experimental arm will receive the cell phone SMS text messaging intervention.
cell phone sms text messaging
At enrollment a study nurse will send the intervention group a weekly SMS message reminding them to attend antenatal care. Starting at 36 weeks gestational age, an automated bulk SMS management system, will send the intervention group 3 SMS text messages (using non descript slogans) each week by proxy reminding them to take their nevirapine in labor. From time of delivery to 6 weeks postpartum the women will aslo receive 3 SMS messages per week reminding them to attend their 6 week checkup and 6 week infant visit.Upon receiving these messages women in the intervention group can text back if they have any concerns or questions. These women would then receive phone calls from the study nurse triaged according to the women's needs.
Control
The control group will receive the standard of care but no SMS text messages.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cell phone sms text messaging
At enrollment a study nurse will send the intervention group a weekly SMS message reminding them to attend antenatal care. Starting at 36 weeks gestational age, an automated bulk SMS management system, will send the intervention group 3 SMS text messages (using non descript slogans) each week by proxy reminding them to take their nevirapine in labor. From time of delivery to 6 weeks postpartum the women will aslo receive 3 SMS messages per week reminding them to attend their 6 week checkup and 6 week infant visit.Upon receiving these messages women in the intervention group can text back if they have any concerns or questions. These women would then receive phone calls from the study nurse triaged according to the women's needs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* are pregnant with a singleton pregnancy,
* attend care at Pumwani Maternity Hospital,
* are HIV positive,
* have never had a preterm birth (before 37 weeks),
* are planning to reside in Nairobi for at least 6 months post delivery,
* live within 15 km of PMH,
* have basic literacy skills in Kiswahili or English,
* are willing to be contacted for follow up and have their own cell phone or regular access to their partners' cell phone (partners must be aware of their HIV status).
Exclusion Criteria
* Women who have had a preterm birth,
* Women who are not planning to reside in Nairobi for at least 6 months post delivery,
* Women who do not live within 15 km of PMH,
* Women who do not have basic literacy skills in English or Kiswahili
* Women who are not willing to be contacted for follow up,
* Women who do not have their own cell phone or regular access to their partner's cell phone and
* Women whose partner's are not aware of their HIV status.
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nairobi
OTHER
Canadian International Development Agency
OTHER_GOV
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Manitoba and UNiversity of Nairobi
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua Kimani, MD
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba and University of Nairobi
Peter Cherutich, MD
Role: PRINCIPAL_INVESTIGATOR
Ministry of Health, NASCOP Kenya
Mary Gichuihi, Masters
Role: STUDY_DIRECTOR
University of Nairobi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pumwani Maternity Hospital
Nairobi, , Kenya
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H2009:315
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.